Tranzactioneaza Bridgebio Pharma Inc (US.BBIO) - 66.8 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 66.020 USD
Ask 69.500 USD
Minim 66.800 USD
Maxim 68.150 USD
Pret referinta 66.800
Volum -
Volum ultima zi 1
Max 52 sapt 84.940 USD
Min 52 sapt 39.650 USD

Descriere companie

BridgeBio Pharma, Inc. (www.bridgebio.com)is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene therapy. The Company’s pipeline programs include product candidates ranging from early discovery to late-stage development. The Company’s products include BBP-561, BBP-711, BBP-631 and BBP-454.

Informatii companie

Nume

BRIDGEBIO PHARMA INC